M&A Deal Summary |
|
|---|---|
| Date | 2019-02-12 |
| Target | Sterling Pharma Solutions |
| Sector | Life Science |
| Buyer(s) | GHO Capital Partners |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2014 |
| PE ASSETS | 6.0B EUR |
| Size | Mega |
| Type | Sector Focused |
GHO Capital Partners is a private investment firm focused on the healthcare sector. The Firm will consider opportunities throughout Europe and seeks well-established, profitable businesses that have the potential to deliver a combination of double-digit top line growth, significant efficiency gains and international expansion. GHO Capital Partners was established in 2014 and is based in London, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 25 |
| Sector: Life Science M&A | 7 of 16 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 5 of 6 |
| Country: United Kingdom M&A | 3 of 4 |
| Year: 2019 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-12-20 |
Eliquent Life Sciences
San Francisco, California, United States Eliquent Life Sciences is a provider of consulting services to a broad range of clients across the biotech, pharma and medtech sectors. Eliquent Life Sciences was founded in 2005 and is based in San Francisco, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-07-18 |
Quotient Sciences
Nottingham, United Kingdom Quotient Sciences is a provider of outsourced, early-stage drug development services to the pharmaceutical industry. Quotient Sciences has brought innovation to the pharmaceutical services sector through its unique Translational Pharmaceutics® platform, which is proven to accelerate development timelines, reduce development costs, and drive improvement in R&D productivity. Quotient Sciences was founded in 1990 and is based in Nottingham, England. |
Sell | - |
